Company outlines near-term pharmacokinetic milestones, highlights amorphous formulation strategy, and announces planned global patent filing TAMPA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Inhibitor ...
On International Transgender Day of Visibility, Kansas should remember the accomplishments of Dr. Alan L. Hart, a doctor and ...
The regulator argues the plans were costly, too theoretical and ineffective, eliminating the financial crisis-era requirement ...